Faster access than browser!Similarities between Olanzapine and Tardive dyskinesia
Olanzapine and Tardive dyskinesia have 16 things in common (in Unionpedia): Antiemetic, Antipsychotic, Aripiprazole, Atypical antipsychotic, Clozapine, Dopamine, Dopamine receptor D3, Dystonia, Extrapyramidal system, Food and Drug Administration, Schizophrenia, Tourette syndrome, Typical antipsychotic, Valproate, 5-HT2A receptor, 5-HT2C receptor.
Antiemetic
An antiemetic is a drug that is effective against vomiting and nausea.
Antiemetic and Olanzapine · Antiemetic and Tardive dyskinesia ·
Antipsychotic
Antipsychotics, also known as neuroleptics or major tranquilizers, are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder.
Antipsychotic and Olanzapine · Antipsychotic and Tardive dyskinesia ·
Aripiprazole
Aripiprazole, sold under the brand name Abilify among others, is an atypical antipsychotic. It is recommended and primarily used in the treatment of schizophrenia and bipolar disorder. Other uses include as an add-on treatment in major depressive disorder, tic disorders, and irritability associated with autism. According to a Cochrane review, evidence for the oral form in schizophrenia is not sufficient to determine effects on general functioning. Additionally, because many people dropped out of the medication trials before they were completed, the overall strength of the conclusions is low. Side effects include neuroleptic malignant syndrome, a movement disorder known as tardive dyskinesia, and high blood sugar in those with diabetes. In the elderly there is an increased risk of death. It is thus not recommended for use in those with psychosis due to dementia. It is pregnancy category C in the United States and category C in Australia, meaning there is possible evidence of harm to the fetus. It is not recommended for women who are breastfeeding. It is unclear whether it is safe or effective in people less than 18 years old. It is a partial dopamine agonist. Aripiprazole was developed by Otsuka in Japan. In the United States, Otsuka America markets it jointly with Bristol-Myers Squibb. From April 2013 to March 2014, sales of Abilify amounted to almost $6.9 billion.
Aripiprazole and Olanzapine · Aripiprazole and Tardive dyskinesia ·
Atypical antipsychotic
The atypical antipsychotics (AAP; also known as second generation antipsychotics (SGAs)) are a group of antipsychotic drugs (antipsychotic drugs in general are also known as major tranquilizers and neuroleptics, although the latter is usually reserved for the typical antipsychotics) used to treat psychiatric conditions.
Atypical antipsychotic and Olanzapine · Atypical antipsychotic and Tardive dyskinesia ·
Clozapine
Clozapine, sold under the brand name Clozaril among others, is an atypical antipsychotic medication.
Clozapine and Olanzapine · Clozapine and Tardive dyskinesia ·
Dopamine
Dopamine (DA, a contraction of 3,4-dihydroxyphenethylamine) is an organic chemical of the catecholamine and phenethylamine families that plays several important roles in the brain and body.
Dopamine and Olanzapine · Dopamine and Tardive dyskinesia ·
Dopamine receptor D3
Dopamine receptor D3 is a protein that in humans is encoded by the DRD3 gene.
Dopamine receptor D3 and Olanzapine · Dopamine receptor D3 and Tardive dyskinesia ·
Dystonia
Dystonia is a neurological movement disorder syndrome in which sustained or repetitive muscle contractions result in twisting and repetitive movements or abnormal fixed postures.
Dystonia and Olanzapine · Dystonia and Tardive dyskinesia ·
Extrapyramidal system
In anatomy, the extrapyramidal system is a part of the motor system network causing involuntary actions.
Extrapyramidal system and Olanzapine · Extrapyramidal system and Tardive dyskinesia ·
Food and Drug Administration
The Food and Drug Administration (FDA or USFDA) is a federal agency of the United States Department of Health and Human Services, one of the United States federal executive departments.
Food and Drug Administration and Olanzapine · Food and Drug Administration and Tardive dyskinesia ·
Schizophrenia
Schizophrenia is a mental disorder characterized by abnormal social behavior and failure to understand reality.
Olanzapine and Schizophrenia · Schizophrenia and Tardive dyskinesia ·
Tourette syndrome
Tourette syndrome (TS or simply Tourette's) is a common neuropsychiatric disorder with onset in childhood, characterized by multiple motor tics and at least one vocal (phonic) tic.
Olanzapine and Tourette syndrome · Tardive dyskinesia and Tourette syndrome ·
Typical antipsychotic
Typical antipsychotics are a class of antipsychotic drugs first developed in the 1950s and used to treat psychosis (in particular, schizophrenia).
Olanzapine and Typical antipsychotic · Tardive dyskinesia and Typical antipsychotic ·
Valproate
Valproate (VPA), and its valproic acid, sodium valproate, and valproate semisodium forms, are medications primarily used to treat epilepsy and bipolar disorder and to prevent migraine headaches.
Olanzapine and Valproate · Tardive dyskinesia and Valproate ·
5-HT2A receptor
The mammalian 5-HT2A receptor is a subtype of the 5-HT2 receptor that belongs to the serotonin receptor family and is a G protein-coupled receptor (GPCR).
5-HT2A receptor and Olanzapine · 5-HT2A receptor and Tardive dyskinesia ·
5-HT2C receptor
The 5-HT2C receptor is a subtype of 5-HT receptor that binds the endogenous neurotransmitter serotonin (5-hydroxytryptamine, 5-HT).
5-HT2C receptor and Olanzapine · 5-HT2C receptor and Tardive dyskinesia ·
The list above answers the following questions
- What Olanzapine and Tardive dyskinesia have in common
- What are the similarities between Olanzapine and Tardive dyskinesia
Olanzapine and Tardive dyskinesia Comparison
Olanzapine has 155 relations, while Tardive dyskinesia has 52. As they have in common 16, the Jaccard index is 7.73% = 16 / (155 + 52).
References
This article shows the relationship between Olanzapine and Tardive dyskinesia. To access each article from which the information was extracted, please visit:
